Related Experiment Video
Updated: Jun 27, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
MicroRNA-30c-1-3p Alleviates Hypoxia-Induced Cardiomyocyte Dysfunction via Tnrc6a Targeting
Jung-Won Choi1,2, Seongtae Jeong2,3, Seung Eun Jung1,2
1Department of Convergence Science, College of Medicine, Catholic Kwandong University, Gangneung-si 25601, Republic of Korea.
Insights
MicroRNA miR-30c-1-3p protects heart cells from damage caused by low oxygen (hypoxia) after myocardial infarction. This protection involves regulating the Tnrc6a gene, offering potential for new heart attack therapies.
Area of Science:
- Cardiology
- Molecular Biology
- Genetics
Background:
- Myocardial infarction (MI) is a major cause of death, leading to cardiomyocyte loss via hypoxia.
- Hypoxia induces mitochondrial dysfunction, oxidative stress, inflammation, and apoptosis, impairing cardiac function.
- MicroRNAs (miRNAs) regulate cardiomyocyte stress responses, but many hypoxia-responsive miRNAs lack defined functions.
Purpose of the Study:
- Investigate the role of miR-30c-1-3p, downregulated in early MI, in hypoxia-induced cardiomyocyte injury.
- Identify and validate downstream targets of miR-30c-1-3p, focusing on Tnrc6a.
Main Methods:
- Utilized primary neonatal rat cardiomyocytes for gain- and loss-of-function studies.
- Performed luciferase reporter assays and Tnrc6a knockdown to assess miR-30c-1-3p effects.
- Evaluated apoptosis, inflammatory cytokine secretion, and myocardial injury markers.
Main Results:
- Restoring miR-30c-1-3p significantly reduced hypoxia-induced apoptosis and inflammation.
- Decreased levels of myocardial injury markers were observed with miR-30c-1-3p restoration.
- Protective effects were linked to the regulation of the miR-30c-1-3p/Tnrc6a axis.
Conclusions:
- Identified a novel role for the miR-30c-1-3p/Tnrc6a axis in mitigating hypoxia-induced cardiomyocyte injury.
- The miR-30c-1-3p/Tnrc6a pathway is a potential therapeutic target for myocardial stress adaptation.
Abstract:
Background/Objectives: Myocardial infarction (MI) remains a leading cause of death worldwide, primarily resulting from abrupt coronary occlusion that induces severe hypoxia and extensive cardiomyocyte loss. Hypoxia triggers mitochondrial dysfunction, oxidative stress, inflammation, and apoptosis, ultimately compromising cardiac function and promoting adverse cardiac remodeling. MicroRNAs (miRNAs) have emerged as critical regulators of cardiomyocyte survival and stress responses under ischemic conditions; however, the functional roles and molecular mechanisms of many hypoxia-responsive miRNAs remain insufficiently defined. Methods: In this study, we focused on miR-30c-1-3p, which is markedly downregulated during the early phase of MI, and investigated its functional role in hypoxia-induced cardiomyocyte injury. We identified trinucleotide repeat-containing 6A (Tnrc6a), a key component of the miRNA-induced silencing complex, as a potential downstream target. Using primary neonatal rat cardiomyocytes, we performed gain- and loss-of-function experiments, luciferase reporter assays, and Tnrc6a knockdown analyses to evaluate apoptosis, inflammatory cytokine secretion, and release of myocardial injury-related proteins. Results: Restoration of miR-30c-1-3p significantly attenuated hypoxia-induced pro-apoptotic signaling, reduced inflammatory cytokine release, and decreased myocardial injury markers. These protective effects were associated with regulation of the miR-30c-1-3p/Tnrc6a axis. Conclusions: Collectively, our findings identify a previously unappreciated functional role of the miR-30c-1-3p/Tnrc6a axis in hypoxia-induced cardiomyocyte injury and highlight its potential relevance in myocardial stress adaptation.